Cardiovascular risk and blood pressure control in a Spanish hypertensive population attended in a Primary Care setting. Data from the PRESCAP 2006 study

Blood Pressure

Volumn 18, Issue 3, 2009, Pages 117-125

  Rodriguezroca, Gustavo C ^a   Llisterricaro, Jose L ^b   Barriosalonso, Vivencio ^c   Alonsomoreno, Francisco J ^d   Louarnal, Salvador ^e   Prietodiaz, Miguel A ^f   Sanchezruiz, Tomas ^b   Durabelinchon, Rafael ^g   Santosrodriguez, Jose A ^h   Divisongarrote, Juan A ⁱ   Gonzalezsegura, Diego ^j   Banegasbanegas, Jose R ^k  

^a Health Care Centre   (Spain)

^b Ingeniero Joaquin Benlloch Health Center   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d Health Care Centre Silleria   (Spain)

^e Health Care Centre   (Spain)

^f Health Care Centre   (Spain)

^g Health Care Centre   (Spain)

^h UNIVERSITY OF A CORUÑA   (Spain)

ⁱ Primary Health Care Centre   (Spain)

^j NONE   (Spain)

^k UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

more..

Author keywords

Cardiovascular risk; Hypertension; Primary care; Risk categories

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ABDOMINAL OBESITY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMORBIDITY; DEMOGRAPHY; DIABETES MELLITUS; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIMARY HEALTH CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SMOKING; SPAIN;

AGED; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HISPANIC AMERICANS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POPULATION GROUPS; POVERTY; PRIMARY HEALTH CARE; RISK FACTORS; SPAIN;

EID: 70849117459     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050902982292     Document Type: Article

References (48)

1. Instituto Nacional De Estadística. Deaths according to Cause of Death. Year 2006. INebase [periodical online publication]. Available from URL: http://www.ine.es/inebmenu/indice.htm
2. Banegas JR, V illar F, Perez C, J iménez R, G il E, M uñiz J, et al. Epidemiological study on cardiovascular risk factors in 35-64 years old population in Spain. Rev San Hig Pub. 1993; 67: 419-445.
3. Banegas JR, Rodríguez-Artalejo F, De La Cruz Troca JJ, Guayar-Castillon P, Del Rey Calero J, Blood Pressure in Spain: distribution, awareness, control and benefits of a reDu ction in average pressure. Hypertension. 1998; 32: 998-1002.
4. Graciani A, Z uluaga-Zuluaga MC, Banegas JR, León-Muñoz LM, De La Cruz JJ, Rodríguez-Artalejo F. Cardiovascular mortality attributable to high blood pressure in Spanish population over 50. Med Clin (Barc). 2008; 131: 125-129.
5. Banegas JR. Epidemiology of arterial hypertension in Spain. Present situation and perspectives. Hipertensión. 2005; 22: 353-362.
6. Integral Plan of Ischemic Cardiopathy 2004-2007. Madrid: Spanish Ministry of Health and Consumption; 2003.
7. Sociedad Española De Hipertensión-Liga Española para la lucha contra la Hipertensión Arterial (SEH-LELHA). 2005 Spanish guidelines of arterial hypertension. Hipertensión. 2005; 22 (Suppl. 2): S1-S84.
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension. 2003; 42: 1206-1252.
9. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003; 21: 1011-1053.
10. Llisterri-Caro JL, Rodríguez-Roca GC, A lonso-Moreno FJ, Banegas-Banegas JR, Barrios-Alonso V, González-Segura D, et al. Control of blood pressure in Spanish hypertensive population attended in primary health-care. PRESCAP 2006 Study. Med Clin (Barc). 2008; 130: 681-687.
11. Coca A. Blood pressure control among treated hypertensive patients by Primary Care in Spain. The 2003 Controlpres study. Hipertensión. 2005; 22: 5-14.
12. Rodríguez-Roca GC, A rtigao-Rodenas LM, Llisterri-Caro JL, Alonso-Moreno FJ, Banegas-Banegas JR, Lou-Arnal S, et al. Control of hypertension in elderly patients receiving primary care in Spain. Rev Esp Cardiol. 2005; 58: 359-366.
13. Llisterri-Caro JL, Alonso-Moreno FJ, Rodríguez-Roca G, Barrios-Alonso V, Lou-Arnal S, Divisón-Garrote JA, et al. Blood pressure control in diabetic hypertensive population attended in primary care setting. "PRESCAP-Diabetes Study". RCAP. 2005; 1: 19-30.
14. Rodríguez-Roca GC, A lonso-Moreno FJ, B arrios V, Llisterri JL, Lou S, Matalí A, et al. Blood pressure fi ndings in Spanish dyslipidemic primary-care patients. LIPICAP-PA Study. Rev Esp Cardiol. 2007; 60: 825-832.
15. Llisterri-Caro JL, Rodriguez-Roca GC, A lonso-Moreno FJ, Lou-Arnal S, Divisón-Garrote JA, Santos-Rodriguez JA, et al. Blood pressure control in Spanish hypertensive patients in Primary Health Care Centres. PRESCAP 2002 Study. Med Clin (Barc). 2004; 122: 165-171.
16. Altman DG, Machin D, Bryant TN, Gardner MJ, editors. Statistics with confi dence. 2nd edn. London: BMJ Books; 2000.
17. Plans P, Tresserras R, Pardell H, S alleras L. Epidemiology of arterial hypertension in the aDult population of Catalonia. Med Clin (Barc). 1992; 98: 369-372.
18. Barrios V, Escobar C, C alderón A, L listerri JL, E charri R, Alegría E, et al. Blood pressure and lipid goal attainment in the hypertensive population in the primary care setting in Spain. J Clin Hypertens. 2007; 9: 324-329.
19. Wang YR, Alexander GC, S tafford RS. Outpatient hypertension treatment, treatment intensifi cation, and control in Western Europe and the United States. Arch Intern Med. 2007; 167: 141-147.
20. Ong KL, C heung BM, Man YB, L au CP, L am KS. Prevalence, awareness, treatment, and control of hypertension among United States aDults 1999-2004. Hypertension. 2007; 49: 69-75.
21. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003; 289: 2363-2369.
22. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003; 24: 1601-1610.
23. Top 10 papers published. The Scientist. 2005; 19: 26.
24. Rodríguez-Roca GC, Llisterri JL, B arrios V, Alonso-Moreno FJ, Banegas JR, Lou S, et al. Control rates of dyslipidemia in Spanish patients assisted in primary care. LIPICAP study. Clin Invest Arterioscl. 2006; 18: 226-238.
25. Banegas JR, V egazo O, S errano P, L uengo E, M antilla T, Fernandez R, et al.; HISPALIPID Study Group Investigators. The gap between dyslipidemia control perceived by physicians and objective control patterns in Spain. Atherosclerosis. 2006; 188: 420-424 .
26. De La Peña A, S uárez C, C uenDe I, M uñoz M, G arré J, Camafort M, et al.; Grupo estudio CIFARC; Grupo Riesgo Vascular SEMI. Integral control of risk factors in patients of high and very high cardiovascular risk in Spain. CIFARC project. Med Clin (Barc). 2005; 124: 44-49
27. Álvarez-Sala LA, S uárez C, Mantilla T, Franch J, Ruilope LM, Banegas JR, et al. PREVENCAT study: Control of cardiovascular risk in primary care. Med Clin (Barc). 2005; 124: 406-410.
28. B arrios-Alonso V, Campuzano-Ruiz R, Peña-Pérez G, Guzmán-Martínez G, Ruilope-Urioste LM. Cardiovascular risk stratifi cation in hypertension in Primary Care medicine and its impact on the prescription of the antihypertensive treatment. DIORISC study. Hipertensión. 2002; 19: 114-120.
29. Barrios V, Escobar C, C alderon A, E charri R, Gonzalez-PeDel V, Ruilope LM. Cardiovascular risk profile and risk stratifi cation of the hypertensive population attended by general practitioners and specialist in Spain. The CONTROLRISK study. J Hum Hypertens. 2007; 21: 479-485.
30. Martín-Baranera M, C ampo C, C oca A, De La Figuera M, Marín R, Ruilope LM. Stratifi cation and degree of control of cardiovascular risk factors in hypertensive Spanish population. Results of the DICOPRESS study. Med Clin (Barc). 2007; 129: 247-251.
31. Mancia G, Volpe R, Boros S, Ilardi M, Giannattasio C. Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care. J Hypertens. 2004; 22: 51-57.
32. D ouglas JG, Bakris GL, Epstein M, F erdinand KC, Ferrario C, Flack JM, et al.; Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. 2003; 163: 525-541.
33. Hallan S, A stor B, R omundstad S, A asarød K, K venild K, Coresh J. Association of kidney function and albuminuria with cardiovascular mortality in older vs. younger indiviDu als: The HUNT II Study. Arch Intern Med. 2007; 167: 2490-2496.
34. Rodríguez-Roca GC, Aznar-Costa J, Llisterri-Caro JL, Alonso-Moreno FJ, Lou-Arnal S, Divisón-Garrote JA, et al. Blood pressure control in patients with heart failure treated in Primary Care centres. Study CARDIOPRES 2004. RCAP. 2006; 1: 15-27.
35. Banegas JR, Rodríguez-Artalejo F, Guallar-Castillón P. Current epidemiology of heart failure in Spain. Rev Esp Cardiol Supl. 2006; 6: 4C-9C.
36. Julius S, N esbitt SD, E gan BM, W eber MA, M ichelson EL, Kaciroti N, et al.; for the Trial of Preventing Hypertension (TROPHY) Study Investigators. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006; 354: 1685-1697.
37. Third Report of The National Cholesterol EDu cation Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol In ADults (ADult Treatment Panel III) final report. Circulation. 2002; 106: 3143-3421.
38. Alberti KG, Z immet P; I DF Epidemiology Task Force Consensus Group. The metabolic syndrome -A new worldwiDe defi nition. Lancet. 2005; 366: 1059-1062. (Pubitemid 41338752)
39. Barrios V, Escobar C, C alderón A, L listerri JL, A legría E, Muñiz J, et al. Prevalence of the metabolic syndrome in patients with hypertension treated in general practice in Spain: an assessment of blood pressure and low-density lipoprotein cholesterol control and accuracy of diagnosis. J Cardiometab Syndr. 2007; 2: 9-15.
40. Rodríguez-Roca GC, Alonso-Moreno FJ, García-Jiménez A, Llisterri-Caro JL. Factors conditioning pulse pressure in type-2 diabetics in a primary care population suffering from hypertension. Aten Primaria. 2003; 31: 486-492.
41. Barrios V, E scobar C, L listerri JL, C alderón A, A legria E, Muñiz J, et al. Blood pressure and lipid control and coronary risk in the hypertensive population attended in Primary Care setting in Spain. The PRESCOT study. Rev Clin Esp. 2007; 207: 172-178. (Pubitemid 46853769)
42. McInnis NH, Fodor G, Lum-Kwong MM, Leenen FH. Antihypertensive medication use and blood pressure control: a community-based cross-sectional survey (ON-BP). Am J Hypertens. 2008; 21: 1210-1215.
43. Nesbitt SD. Antihypertensive combination therapy: optimizing blood pressure control and cardiovascular risk reDu ction. J Clin Hypertens. 2007; 9 (11 suppl.):4 26-32.
44. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007; 28: 1462-1536.
45. Turnbull F, N eal B, A lgert C, C halmers J, C hapman N, Cutler J, et al.; for the Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood pressurelowering regimens on major cardiovascular events in indiviDu als with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med. 2005; 165: 1410-1419.
46. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). European guidelines on cardiovascular disease prevention in clinical practice: Executive summary. Eur Heart J. 2007; 28: 2375-2414.
47. Sans S, F itzgerald AP, Royo D, C onroy R, G raham I. Calibrating the SCORE cardiovascular risk chart for use in Spain. Rev Esp Cardiol. 2007; 60: 476-485.
48. Lobos JM, R oyo-Bordonada MA, B rotons C, Á lvarez-Sala L, Armario P, Maiques A, et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice: CEIPC 2008 Spanish Adaptation. Rev Esp Salud Publica. 2008; 82: 581-616.